granisetron has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Rihani, SB; Kaddoumi, A; Lan, RS | 1 |
1 other study(ies) available for granisetron and Alzheimer Disease
| Article | Year |
|---|---|
Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Brain; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Granisetron; Maze Learning; Mice; Mice, Transgenic; Neuroprotective Agents; Signal Transduction | 2019 |